Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study

Launched by INCHEON ST.MARY'S HOSPITAL · Jul 11, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how well doctors can predict the size of breast tumors before surgery compared to the actual size after the tumor has been removed. The goal is to find out if using different methods to assess the tumor size can help improve surgical planning. This is important because if the tumor isn't completely removed, patients may need to go through surgery again, which can be stressful and costly. By gathering information from imaging tests and other factors, the study hopes to reduce the chances of needing additional surgeries and improve outcomes for women with breast cancer.

To participate in this study, you need to be an adult (19 years or older) who has been diagnosed with breast cancer and is scheduled for surgery to remove the tumor. However, if you have recurrent breast cancer, inflammatory breast cancer, or if your pre-surgery tumor size information is incomplete, you won't be eligible to join. If you decide to participate, you can expect to help researchers collect important data that could improve surgical treatment for future breast cancer patients. The study is currently recruiting participants of all genders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (≥ 19 years old) diagnosed with breast cancer (invasive and in situ).
• • Patients scheduled for surgical resection of the tumor Availability of both preoperative tumor size assessments and pathologic measurements post-surgery
• Exclusion Criteria:
• • Patients with recurrent breast cancer Inflammatory breast cancer Patients who did not undergo surgery Patients whose preoperative tumor size data is not available or deficient for analyzing